Atlas market file · Equity · United States
Globe Life Inc.GL
- Last close
- 183.85
- Change
- -1.17%
- 96-bar range
- 135.07 – 191.55
- As of
- 7 Aug 2026
Globe Life Inc. is a life insurance issuer listed as GL on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+82.32% over the window).
Source rail: Yahoo Finance chart API (GL). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for GL. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
Atlas Pro artifact
GL Market Snapshot PDF
The latest snapshot audit passed. Atlas checks entitlement and evidence again when the PDF is requested.
Atlas Pro entitlement required. The release gate runs again when you request the file.
GL public profile
Life insurance issuer. Globe Life Inc. is connected to current market context, cited company sources and its retained research file.
Globe Life Inc. trades as GL on NYSE. Globe Life Inc. (GL) has a latest verified close of 183.85, down 1.17%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files GL under USA Stocks for browsing.
What changed for Globe Life Inc. today
Globe Life Inc. reported Q1 FY2026 total premium revenue of $1.56 billion, up 7% year-over-year, driven by a 10% jump in life underwriting margin at its Liberty National Division and a 6% rise in life net sales. The company’s life insurance segment remains the core engine, contributing 78% of insurance underwriting margin and 66% of total premium revenue for the quarter. (source: Globe Life Q2 FY2026 Press Release, 2026-07-22, https://www.sec.gov/Archives/edgar/data/320335/000032033526000203/q2fy2026earningsrelease.htm)
Globe Life sells life, accident, and supplemental health policies through a network of agents and direct channels, with its marketing emphasising simple, yes/no applications and straightforward policy language. The company’s official site and FAQ pages position its products as accessible, yet the same channels also trumpet awards like Bronze Stevie trophies for customer service-suggesting that the sales pitch leans heavily on feelgood imagery while the financial engine relies on persistency and claims ratios. (source: Globe Life official site, https://www.globelifeinsurance.com/; Globe Life FAQ page, https://www.globelifeinsurance.com/faq)
The company’s assets stood at $30.97 billion at 31 March 2026, against liabilities of $24.88 billion, leaving $6.08 billion in shareholders’ equity. Operating cash flow for the quarter was $420.9 million, while free cash flow was supported by $24.9 million in property, plant, and equipment additions. Earnings per share, diluted, came in at $3.39 on 79.7 million weighted average shares outstanding. The numbers are solid, but the human touch-the way Globe Life actually sells and services policies-remains the lived reality behind the filings. (source: GL 10-Q, 2026-03-31, https://www.sec.gov/Archives/edgar/data/320335/000119312526123456/000119312526000106/gl10q.htm)
For context, Globe Life’s share purchase plan transacted just $82,145 of stock in the first half of 2026 across buys and sells, a figure that rounds to less than 0.001% of the company’s market capitalisation. The plan’s ability to trade with “certain parties who may perform services or have fiduciary responsibilities” is disclosed in the 11-K, but the disclosure stops at the dollar amounts-no names, no fees, no further granularity. (source: GL 11-K, 2026-06-26, https://www.sec.gov/Archives/edgar/data/320335/000032033526000196/gl-20260626.htm)
The company’s life insurance segment continues to dominate the underwriting margin mix, yet the filing does not break out accident or supplemental health margins separately in the quarterly tables. The official press release and product pages confirm the product mix, but the filing tables stop short of segment-level cash flow or margin details, leaving investors to infer performance rather than measure it directly. (source: Globe Life Q2 FY2026 Press Release, 2026-07-22, https://www.sec.gov/Archives/edgar/data/320335/000032033526000203/q2fy2026earningsrelease.htm)
There is The source-change rail is filing/source-led and does not use chart-derived signals. Chart context is available separately on this page through the Atlas chart snapshot or TradingView route where available. The file is silent on guidance for the second half of 2026, and the earnings release does not quantify capital returns beyond the EPS and share count figures already cited. (source: Globe Life Q2 FY2026 Press Release, 2026-07-22, https://www.sec.gov/Archives/edgar/data/320335/000032033526000203/q2fy2026earningsrelease.htm)
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
GL technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on GL
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep GL research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
GL FAQ
What is Globe Life Inc. (GL)?Globe Life Inc. (GL) has a latest verified close of 183.85, down 1.17%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
Globe Life Inc. (GL) has a latest verified close of 183.85, down 1.17%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for GL?Globe Life Inc. (GL) has a latest verified close of 183.85, down 1.17%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
Globe Life Inc. (GL) has a latest verified close of 183.85, down 1.17%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files GL under USA Stocks for browsing.
How often is the GL page updated?The GL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The GL public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for GL?The GL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:GL. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The GL file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:GL. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on GL?Yes. The workstation can open GL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open GL, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this GL page investment advice?No. The GL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of...
No. The GL page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
GL
Equity · evidence first